抗癌药零关税政策下医保基金平衡--基于供方视角分析【摘要】2018 年 5 月 1 日，中国开始实施进口抗癌药零关税的政策。在此基础上，中国陆续颁布了多项抗癌药政策，主要的目的就是将抗癌药纳入医保。在抗癌药如今需求巨大的背景下，抗癌药纳入医保带来了巨额报销支出，因此，如何保证医保基金在抗癌药物方面的收支平衡，保障人民的医疗需求，为此社会的稳定成了重中之重。本次研究就抗癌药报销的金额的发展趋势进行分析，在增加保费和国家拨款成立专项基金这两个方法之间，粗略预测未来形势，对比两者之间的优缺点，判断双方是否符合国家实际发展情况。最终得出增加保费这一方法以其对人民群众带来的负担小，能缓解医保基金整体收支压力的优点，成为更符合中国现今需大力发展国家经济这一国情的解决方法。【关键词】医保基金平衡；医保基金收入；抗癌药政策注：本论文（设计）题目来源于教师的国家级（或省部级、厅级、市级、校级、企业）科研项目，项目编号为： 2018WQNCX064 。Balance of medical insurance fund under zero tariff policy of anticancer drugs[Abstract] On May 1st, 2018, China began to implement the zero tariff policy for the import of anti-cancer drugs. On this basis, China has successively promulgated a number of anti-cancer drug policies, the main purpose of which is to include anti-cancer drugs in medical insurance. In the context of huge demand for anticancer drugs, the inclusion of anticancer drugs into the medical insurance has brought huge reimbursement expenses. Therefore, how to ensure the balance of medical insurance fund's income and expenditure in the field of anticancer drugs and protect the people's medical demand has become the top priority for social stability. This study analyzes the development trend of the amount of reimbursement for anticancer drugs, roughly forecasts the future situation between the two methods of increasing the premium and establishing the special fund with the state funding, compares the advantages and disadvantages between t...
